Hampar Karageozian

Mr. Karageozian has over 47 years of distinguished service in ophthalmic drug development. During his career, Mr. Karageozian has brought over 30 ophthalmic drugs to market and is an author or co-author of more than 150 worldwide issued patents. Mr. Karageozian is the co-founder and Chief Technical Officer of Allegro Ophthalmics. Previously, Mr. Karageozian was the co-founder and CTO of ISTA Pharmaceuticals, Inc., and served as CEO at Allegro, PrimaPharma, Inc., S K Pharmaceuticals, Inc., and Vitreoretinal Technologies, Inc. He has previously raised numerous rounds of venture capital funding for several of these companies, as well as active involvement in the initial public offering of ISTA Pharmaceuticals.

Prior to co-founding PrimaPharma, Inc., Mr. Karageozian spent 23 years at Allergan Pharmaceuticals, Inc. in senior management positions, including corporate head of research and development. Mr. Karageozian’s extensive experience and expertise spans well beyond research and development to include drug discovery and development, domestic and international regulatory affairs, clinical studies, and API and finished product manufacturing.

Mr. Karageozian received his BSc in Pharmacy from American University of Beirut, his MSc in Biochemistry from MIT, and his MBA from the University of California, Irvine.